population-based approach to define body-composition phenotypes

Background: Abnormal body compositions such as high adiposity (HA), low muscle mass (LM), or a combination of the 2 [high adiposity with low muscle mass (HA-LM)] are relevant phenotypes, but data on their prevalence and impact on health are still limited. This is largely because of a lack of a conse...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of clinical nutrition Vol. 99; no. 6; pp. 1369 - 1377
Main Authors Prado, Carla MM, Siervo, Mario, Mire, Emily, Heymsfield, Steven B, Stephan, Blossom CM, Broyles, Stephanie, Smith, Steven R, Wells, Jonathan CK, Katzmarzyk, Peter T
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Nutrition 01.06.2014
American Society for Clinical Nutrition, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Abnormal body compositions such as high adiposity (HA), low muscle mass (LM), or a combination of the 2 [high adiposity with low muscle mass (HA-LM)] are relevant phenotypes, but data on their prevalence and impact on health are still limited. This is largely because of a lack of a consensus definition for these conditions. Of particular interest is the HA-LM phenotype, also termed “sarcopenic obesity,” which may confer greater health risk.Objective: We propose a new approach for operationalizing abnormal body-composition phenotypes in a representative adult population.Design: Whole-body dual-energy X-ray absorptiometry data obtained from the 1999–2004 NHANES were analyzed for 13,236 subjects aged ≥18 y (maximum weight and height of 136 kg and 1.96 m, respectively). Sex- and body mass index (BMI)–specific decile groups of appendicular skeletal muscle index (ASMI; kg/m2) and fat mass index (FMI; kg/m2) were developed. Cutoffs for HA and LM were incorporated into a diagnostic framework to characterize 4 specific body-composition phenotypes—low adiposity with high muscle mass, high adiposity with high muscle mass, low adiposity with low muscle mass, and HA-LM—and a subclassification of the phenotypes into classes I, II, and III.Results: Abnormal phenotypes were prevalent across the age spectrum and BMI categories. The association between ASMI or FMI and age was modified by sex and BMI. The prevalence of HA-LM in the whole sample was 10.3% in women and 15.2% in men. The prevalence of all subclasses of HA-LM in obese women and men was 14.7% and 22.9%, respectively. HA-LM class III was more prevalent in obese men (2.3%) than in obese women (0.3%).Conclusions: We developed sex- and BMI-specific reference curves to harmonize the classification of body-composition phenotypes. The application of this classification will be particularly useful in the identification of cases of sarcopenic obesity. The association of these phenotypes with metabolic deregulation and increased disease risk awaits verification.
AbstractList Background: Abnormal body compositions such as high adiposity (HA), low muscle mass (LM), or a combination of the 2 [high adiposity with low muscle mass (HA-LM)] are relevant phenotypes, but data on their prevalence and impact on health are still limited. This is largely because of a lack of a consensus definition for these conditions. Of particular interest is the HA-LM phenotype, also termed “sarcopenic obesity,” which may confer greater health risk.Objective: We propose a new approach for operationalizing abnormal body-composition phenotypes in a representative adult population.Design: Whole-body dual-energy X-ray absorptiometry data obtained from the 1999–2004 NHANES were analyzed for 13,236 subjects aged ≥18 y (maximum weight and height of 136 kg and 1.96 m, respectively). Sex- and body mass index (BMI)–specific decile groups of appendicular skeletal muscle index (ASMI; kg/m2) and fat mass index (FMI; kg/m2) were developed. Cutoffs for HA and LM were incorporated into a diagnostic framework to characterize 4 specific body-composition phenotypes—low adiposity with high muscle mass, high adiposity with high muscle mass, low adiposity with low muscle mass, and HA-LM—and a subclassification of the phenotypes into classes I, II, and III.Results: Abnormal phenotypes were prevalent across the age spectrum and BMI categories. The association between ASMI or FMI and age was modified by sex and BMI. The prevalence of HA-LM in the whole sample was 10.3% in women and 15.2% in men. The prevalence of all subclasses of HA-LM in obese women and men was 14.7% and 22.9%, respectively. HA-LM class III was more prevalent in obese men (2.3%) than in obese women (0.3%).Conclusions: We developed sex- and BMI-specific reference curves to harmonize the classification of body-composition phenotypes. The application of this classification will be particularly useful in the identification of cases of sarcopenic obesity. The association of these phenotypes with metabolic deregulation and increased disease risk awaits verification.
Abnormal body compositions such as high adiposity (HA), low muscle mass (LM), or a combination of the 2 [high adiposity with low muscle mass (HA-LM)] are relevant phenotypes, but data on their prevalence and impact on health are still limited. This is largely because of a lack of a consensus definition for these conditions. Of particular interest is the HA-LM phenotype, also termed "sarcopenic obesity," which may confer greater health risk. We propose a new approach for operationalizing abnormal body-composition phenotypes in a representative adult population. Whole-body dual-energy X-ray absorptiometry data obtained from the 1999-2004 NHANES were analyzed for 13,236 subjects aged ≥18 y (maximum weight and height of 136 kg and 1.96 m, respectively). Sex- and body mass index (BMI)-specific decile groups of appendicular skeletal muscle index (ASMI; kg/m2) and fat mass index (FMI; kg/m2) were developed. Cutoffs for HA and LM were incorporated into a diagnostic framework to characterize 4 specific body-composition phenotypes -- low adiposity with high muscle mass, high adiposity with high muscle mass, low adiposity with low muscle mass, and HA-LM -- and a subclassification of the phenotypes into classes I, II, and III. Abnormal phenotypes were prevalent across the age spectrum and BMI categories. The association between ASMI or FMI and age was modified by sex and BMI. The prevalence of HA-LM in the whole sample was 10.3% in women and 15.2% in men. The prevalence of all subclasses of HA-LM in obese women and men was 14.7% and 22.9%, respectively. HA-LM class III was more prevalent in obese men (2.3%) than in obese women (0.3%). We developed sex- and BMI-specific reference curves to harmonize the classification of body-composition phenotypes. The application of this classification will be particularly useful in the identification of cases of sarcopenic obesity. The association of these phenotypes with metabolic deregulation and increased disease risk awaits verification.
Abnormal body compositions such as high adiposity (HA), low muscle mass (LM), or a combination of the 2 [high adiposity with low muscle mass (HA-LM)] are relevant phenotypes, but data on their prevalence and impact on health are still limited. This is largely because of a lack of a consensus definition for these conditions. Of particular interest is the HA-LM phenotype, also termed "sarcopenic obesity," which may confer greater health risk.BACKGROUNDAbnormal body compositions such as high adiposity (HA), low muscle mass (LM), or a combination of the 2 [high adiposity with low muscle mass (HA-LM)] are relevant phenotypes, but data on their prevalence and impact on health are still limited. This is largely because of a lack of a consensus definition for these conditions. Of particular interest is the HA-LM phenotype, also termed "sarcopenic obesity," which may confer greater health risk.We propose a new approach for operationalizing abnormal body-composition phenotypes in a representative adult population.OBJECTIVEWe propose a new approach for operationalizing abnormal body-composition phenotypes in a representative adult population.Whole-body dual-energy X-ray absorptiometry data obtained from the 1999-2004 NHANES were analyzed for 13,236 subjects aged ≥18 y (maximum weight and height of 136 kg and 1.96 m, respectively). Sex- and body mass index (BMI)-specific decile groups of appendicular skeletal muscle index (ASMI; kg/m²) and fat mass index (FMI; kg/m²) were developed. Cutoffs for HA and LM were incorporated into a diagnostic framework to characterize 4 specific body-composition phenotypes-low adiposity with high muscle mass, high adiposity with high muscle mass, low adiposity with low muscle mass, and HA-LM-and a subclassification of the phenotypes into classes I, II, and III.DESIGNWhole-body dual-energy X-ray absorptiometry data obtained from the 1999-2004 NHANES were analyzed for 13,236 subjects aged ≥18 y (maximum weight and height of 136 kg and 1.96 m, respectively). Sex- and body mass index (BMI)-specific decile groups of appendicular skeletal muscle index (ASMI; kg/m²) and fat mass index (FMI; kg/m²) were developed. Cutoffs for HA and LM were incorporated into a diagnostic framework to characterize 4 specific body-composition phenotypes-low adiposity with high muscle mass, high adiposity with high muscle mass, low adiposity with low muscle mass, and HA-LM-and a subclassification of the phenotypes into classes I, II, and III.Abnormal phenotypes were prevalent across the age spectrum and BMI categories. The association between ASMI or FMI and age was modified by sex and BMI. The prevalence of HA-LM in the whole sample was 10.3% in women and 15.2% in men. The prevalence of all subclasses of HA-LM in obese women and men was 14.7% and 22.9%, respectively. HA-LM class III was more prevalent in obese men (2.3%) than in obese women (0.3%).RESULTSAbnormal phenotypes were prevalent across the age spectrum and BMI categories. The association between ASMI or FMI and age was modified by sex and BMI. The prevalence of HA-LM in the whole sample was 10.3% in women and 15.2% in men. The prevalence of all subclasses of HA-LM in obese women and men was 14.7% and 22.9%, respectively. HA-LM class III was more prevalent in obese men (2.3%) than in obese women (0.3%).We developed sex- and BMI-specific reference curves to harmonize the classification of body-composition phenotypes. The application of this classification will be particularly useful in the identification of cases of sarcopenic obesity. The association of these phenotypes with metabolic deregulation and increased disease risk awaits verification.CONCLUSIONSWe developed sex- and BMI-specific reference curves to harmonize the classification of body-composition phenotypes. The application of this classification will be particularly useful in the identification of cases of sarcopenic obesity. The association of these phenotypes with metabolic deregulation and increased disease risk awaits verification.
Abnormal body compositions such as high adiposity (HA), low muscle mass (LM), or a combination of the 2 [high adiposity with low muscle mass (HA-LM)] are relevant phenotypes, but data on their prevalence and impact on health are still limited. This is largely because of a lack of a consensus definition for these conditions. Of particular interest is the HA-LM phenotype, also termed "sarcopenic obesity," which may confer greater health risk. We propose a new approach for operationalizing abnormal body-composition phenotypes in a representative adult population. Whole-body dual-energy X-ray absorptiometry data obtained from the 1999-2004 NHANES were analyzed for 13,236 subjects aged ≥18 y (maximum weight and height of 136 kg and 1.96 m, respectively). Sex- and body mass index (BMI)-specific decile groups of appendicular skeletal muscle index (ASMI; kg/m²) and fat mass index (FMI; kg/m²) were developed. Cutoffs for HA and LM were incorporated into a diagnostic framework to characterize 4 specific body-composition phenotypes-low adiposity with high muscle mass, high adiposity with high muscle mass, low adiposity with low muscle mass, and HA-LM-and a subclassification of the phenotypes into classes I, II, and III. Abnormal phenotypes were prevalent across the age spectrum and BMI categories. The association between ASMI or FMI and age was modified by sex and BMI. The prevalence of HA-LM in the whole sample was 10.3% in women and 15.2% in men. The prevalence of all subclasses of HA-LM in obese women and men was 14.7% and 22.9%, respectively. HA-LM class III was more prevalent in obese men (2.3%) than in obese women (0.3%). We developed sex- and BMI-specific reference curves to harmonize the classification of body-composition phenotypes. The application of this classification will be particularly useful in the identification of cases of sarcopenic obesity. The association of these phenotypes with metabolic deregulation and increased disease risk awaits verification.
Author Katzmarzyk, Peter T
Smith, Steven R
Broyles, Stephanie
Siervo, Mario
Heymsfield, Steven B
Wells, Jonathan CK
Stephan, Blossom CM
Prado, Carla MM
Mire, Emily
Author_xml – sequence: 1
  fullname: Prado, Carla MM
– sequence: 2
  fullname: Siervo, Mario
– sequence: 3
  fullname: Mire, Emily
– sequence: 4
  fullname: Heymsfield, Steven B
– sequence: 5
  fullname: Stephan, Blossom CM
– sequence: 6
  fullname: Broyles, Stephanie
– sequence: 7
  fullname: Smith, Steven R
– sequence: 8
  fullname: Wells, Jonathan CK
– sequence: 9
  fullname: Katzmarzyk, Peter T
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24760978$$D View this record in MEDLINE/PubMed
BookMark eNqNkb1v2zAUxIkiQeykmbu1ArJ0kcPHT3EqiiBNCwTIEHcmKPKpliGLqigN_u9Lx_ESoECmt_zu8O7ukpz1sUdCPgFdcSPkrdv6fgXAV1RXUqsPZAmGVyVnVJ-RJaWUlQaUXJDLlLaUAhOVuiALJrSiRldL8m2Iw9y5qY19WbuEoXDDMEbnN8UUi4BN22NRx7AvfdwNMbUHshg22MdpP2D6SM4b1yW8fr1XZP3jfn33s3x8evh19_2x9KIyUxnq2vOK5Q8QQDeKaQZCCQzOU2TIRKMqpoNjzoADVB6DDoYKY6gEQ_kV-Xq0zb_9nTFNdtcmj13neoxzsqByfqa14e9ApdEq5xcZvXmDbuM89jmHBckZy6CATH1-peZ6h8EOY7tz496eSsyAPAJ-jCmN2FjfTi-VTqNrOwvUHsayh7FsHssex8q62ze6k_X_FV-OisZF6_6MbbK_nxkFmYuVQIXk_wC4kJ59
CitedBy_id crossref_primary_10_1016_j_clnu_2017_09_021
crossref_primary_10_1038_nrdp_2017_34
crossref_primary_10_13066_kspm_2023_18_4_37
crossref_primary_10_1016_j_clnu_2021_01_005
crossref_primary_10_1186_s13098_015_0016_5
crossref_primary_10_1093_advances_nmab153
crossref_primary_10_34175_jno201601004
crossref_primary_10_1002_oby_24157
crossref_primary_10_1016_j_jocd_2022_01_002
crossref_primary_10_1038_ejcn_2015_185
crossref_primary_10_3389_fphys_2020_583825
crossref_primary_10_3390_jcm10153445
crossref_primary_10_1002_ncp_10374
crossref_primary_10_3945_an_115_008755
crossref_primary_10_1007_s11912_015_0488_3
crossref_primary_10_1111_nyas_12498
crossref_primary_10_1016_j_acra_2017_07_007
crossref_primary_10_3390_cancers14071846
crossref_primary_10_1515_revce_2016_0018
crossref_primary_10_1152_japplphysiol_00799_2015
crossref_primary_10_3945_cdn_117_001743
crossref_primary_10_2196_22989
crossref_primary_10_1016_j_clnu_2016_11_012
crossref_primary_10_1038_s41430_018_0340_6
crossref_primary_10_1155_2017_7307618
crossref_primary_10_1016_j_envpol_2021_118247
crossref_primary_10_3390_nu12030755
crossref_primary_10_1186_s40814_022_01137_6
crossref_primary_10_3945_ajcn_116_134221
crossref_primary_10_1093_ageing_afy143
crossref_primary_10_1016_j_clnu_2024_10_037
crossref_primary_10_20945_2359_3997000000124
crossref_primary_10_1007_s11690_017_0555_z
crossref_primary_10_1016_j_maturitas_2014_12_023
crossref_primary_10_1152_japplphysiol_00162_2017
crossref_primary_10_1186_s12893_024_02408_0
crossref_primary_10_3945_ajcn_114_099697
crossref_primary_10_1007_s13679_016_0228_5
crossref_primary_10_1007_s11357_024_01245_6
crossref_primary_10_1016_j_nut_2022_111838
crossref_primary_10_1016_j_clnu_2019_11_024
crossref_primary_10_1080_07853890_2018_1511918
crossref_primary_10_1038_s41366_024_01511_9
crossref_primary_10_1016_S2213_8587_18_30204_3
crossref_primary_10_1210_clinem_dgac662
crossref_primary_10_1177_0148607114550189
crossref_primary_10_3389_fendo_2022_990442
crossref_primary_10_53435_funj_00978
crossref_primary_10_1513_AnnalsATS_202111_1221OC
crossref_primary_10_1159_000518638
crossref_primary_10_1002_ncp_10230
crossref_primary_10_1016_j_jocd_2019_02_002
crossref_primary_10_1007_s11912_016_0522_0
crossref_primary_10_1016_j_ajo_2016_09_031
crossref_primary_10_13066_kspm_2023_18_3_1
crossref_primary_10_1183_09031936_00197314
crossref_primary_10_1371_journal_pone_0174180
crossref_primary_10_1002_jcsm_13714
crossref_primary_10_3389_fendo_2023_1077255
crossref_primary_10_1007_s11695_021_05530_7
crossref_primary_10_1016_j_ypmed_2022_107282
crossref_primary_10_1016_j_reuma_2015_03_005
crossref_primary_10_1016_j_clnu_2021_12_024
crossref_primary_10_1016_j_jocd_2021_07_013
crossref_primary_10_3889_oamjms_2022_9618
crossref_primary_10_1016_j_jhevol_2016_09_001
crossref_primary_10_1007_s00774_019_01071_3
crossref_primary_10_1016_j_clnu_2018_01_022
crossref_primary_10_1080_01635581_2022_2044059
crossref_primary_10_1016_j_jvs_2021_08_051
crossref_primary_10_1038_s41598_024_54102_z
crossref_primary_10_13066_kspm_2024_19_1_31
crossref_primary_10_1016_j_clnu_2018_12_002
crossref_primary_10_3390_ijerph20021140
crossref_primary_10_1016_j_bone_2017_06_010
crossref_primary_10_1186_s12944_025_02437_5
crossref_primary_10_36384_01232576_559
crossref_primary_10_1016_j_advnut_2024_100364
crossref_primary_10_1002_rco2_70
crossref_primary_10_1016_j_jocd_2020_02_003
crossref_primary_10_1371_journal_pone_0142101
crossref_primary_10_3390_children8111047
crossref_primary_10_3390_nu15234932
crossref_primary_10_1016_j_clnesp_2022_10_010
crossref_primary_10_1080_01635581_2022_2081341
crossref_primary_10_3390_nu13072350
crossref_primary_10_1016_j_metabol_2018_12_012
crossref_primary_10_3390_ijerph14070809
crossref_primary_10_1159_000445380
crossref_primary_10_1186_s12891_018_2175_7
crossref_primary_10_1016_j_nut_2024_112526
crossref_primary_10_13066_kspm_2023_18_3_11
crossref_primary_10_1007_s00394_015_1000_4
crossref_primary_10_1016_j_bone_2024_117170
crossref_primary_10_1097_MCO_0000000000000216
crossref_primary_10_3390_nu9010023
crossref_primary_10_3390_jcm11082118
crossref_primary_10_1016_j_clnu_2020_11_031
crossref_primary_10_4093_dmj_2018_0141
crossref_primary_10_1016_j_clnesp_2018_07_005
crossref_primary_10_1002_jcsm_12712
crossref_primary_10_1111_jhn_12372
crossref_primary_10_1016_j_reumae_2015_03_013
crossref_primary_10_51745_najfnr_6_13_55_65
crossref_primary_10_1016_j_clnu_2016_12_028
crossref_primary_10_1097_MD_0000000000038422
crossref_primary_10_1080_27697061_2024_2333310
crossref_primary_10_3748_wjg_v22_i2_681
crossref_primary_10_1183_09059180_00010914
crossref_primary_10_3390_cancers15184600
crossref_primary_10_1007_s12018_016_9206_4
crossref_primary_10_1002_oby_23197
crossref_primary_10_1038_s41598_018_37347_3
crossref_primary_10_20945_2359_3997000000551
crossref_primary_10_1111_resp_14100
crossref_primary_10_1016_j_clnu_2023_03_006
crossref_primary_10_1007_s13410_015_0402_4
crossref_primary_10_1016_j_nut_2020_110765
crossref_primary_10_1017_S0029665115004206
crossref_primary_10_51745_najfnr_6_14_94_106
crossref_primary_10_1080_09637486_2021_1984401
crossref_primary_10_1038_s41366_021_00995_z
crossref_primary_10_23736_S0031_0808_22_04784_X
crossref_primary_10_1016_j_exger_2022_111991
crossref_primary_10_1038_s41430_020_0596_5
Cites_doi 10.1038/sj.ejcn.1601024
10.1097/01.mol.0000319118.44995.9a
10.1016/j.clnu.2012.08.016
10.1385/JCD:8:3:293
10.1093/oxfordjournals.aje.a009520
10.1038/oby.2004.111
10.1093/ajcn/69.5.1007
10.1371/journal.pone.0007038
10.1111/j.1532-5415.2004.52014.x
10.1210/jc.2004-0535
10.1111/j.1749-6632.2000.tb06498.x
10.1097/gme.0b013e31825d26b6
10.1056/NEJMoa1007137
10.1038/oby.2004.250
10.1093/ajcn/52.2.214
10.1038/oby.2005.42
10.1016/j.cger.2011.03.007
10.1002/sim.1692
10.1093/ajcn/81.5.1018
10.1002/art.37696
10.1097/MCO.0b013e32833aabd9
10.1111/j.1749-6632.2000.tb06515.x
10.1093/ajcn/64.3.472S
10.1016/j.numecd.2011.12.001
10.3945/ajcn.2008.26847
10.1016/j.orcp.2011.05.001
10.1007/BF02992693
10.1016/j.clnu.2012.06.010
10.1038/oby.2004.107
10.1093/gerona/55.12.M716
10.1016/S1470-2045(08)70153-0
ContentType Journal Article
Copyright 2014 American Society for Nutrition.
Copyright American Society for Clinical Nutrition, Inc. Jun 1, 2014
Copyright_xml – notice: 2014 American Society for Nutrition.
– notice: Copyright American Society for Clinical Nutrition, Inc. Jun 1, 2014
DBID FBQ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T7
7TS
8FD
C1K
FR3
K9.
NAPCQ
P64
7X8
7S9
L.6
DOI 10.3945/ajcn.113.078576
DatabaseName AGRIS
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Physical Education Index
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Calcium & Calcified Tissue Abstracts
Physical Education Index
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
Nursing & Allied Health Premium
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Diet & Clinical Nutrition
EISSN 1938-3207
EndPage 1377
ExternalDocumentID 3324641091
24760978
10_3945_ajcn_113_078576
US201500151045
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-ET
-~X
..I
.55
.GJ
0R~
1HT
23M
2FS
2WC
3O-
4.4
48X
53G
5GY
5RE
5VS
6J9
85S
8R4
8R5
AABZA
AACZT
AAGQS
AAHBH
AAIKC
AAJQQ
AAMNW
AAPGJ
AAPQZ
AAUQX
AAUTI
AAVAP
AAWDT
AAWTL
AAXUO
AAYOK
ABBTP
ABDNZ
ABDPE
ABIME
ABJNI
ABLJU
ABOCM
ABPTD
ABWST
ACFRR
ACGFO
ACGFS
ACGOD
ACNCT
ACPRK
ACPVT
ACUFI
ACUTJ
ADBBV
ADGZP
ADHUB
ADMTO
ADRTK
ADUKH
ADVEK
ADVLN
AEGXH
AENEX
AETBJ
AFFDN
AFFNX
AFFZL
AFJKZ
AFOFC
AFRAH
AFXAL
AGINJ
AGKRT
AGNAY
AGQXC
AGUTN
AHMBA
AI.
AIAGR
AITUG
AJEEA
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANFBD
AQDSO
AQKUS
BAWUL
BAYMD
BKOMP
BTRTY
C1A
CDBKE
DAKXR
DIK
E3Z
EBS
EIHJH
EJD
ENERS
EX3
F5P
F9R
FBQ
FDB
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
FRP
GAUVT
GJXCC
GX1
H13
HF~
HZ~
IH2
J5H
KBUDW
KOP
KQ8
KSI
KSN
L7B
LPU
MBLQV
MHKGH
MV1
MVM
N4W
NEJ
NHB
NHCRO
NOMLY
NOYVH
NVLIB
O9-
ODMLO
OHT
OK1
OVD
P2P
P6G
PCD
PQQKQ
PRG
Q2X
R0Z
RHI
RNS
ROL
SJN
TCN
TEORI
TMA
TNT
TR2
TWZ
UBH
UHB
UKR
VH1
W2D
W8F
WH7
WHG
WOQ
WOW
X7M
XOL
XSW
YBU
YHG
YOJ
YQJ
YR5
YRY
YSK
YV5
YYQ
YZZ
ZCA
ZCG
ZGI
ZUP
ZXP
~KM
AALRI
AAYWO
AAYXX
ACVFH
ADCNI
AEUPX
AFPUW
AGCQF
AIGII
AKBMS
AKYEP
APXCP
CITATION
NU-
A8Z
ABSAR
BCRHZ
CGR
CUY
CVF
ECM
EIF
NPM
RHF
ROX
SV3
VXZ
Z5M
7QP
7T7
7TS
8FD
C1K
EFKBS
FR3
K9.
NAPCQ
P64
7X8
7S9
L.6
ID FETCH-LOGICAL-c489t-dbbc382001e117f62721464edac0e2e24f6827da2a91a1e6ced7d90499051903
ISSN 0002-9165
1938-3207
IngestDate Fri Jul 11 05:10:18 EDT 2025
Fri Jul 11 12:16:01 EDT 2025
Fri Jul 25 06:43:22 EDT 2025
Wed Feb 19 02:24:42 EST 2025
Tue Jul 01 04:03:02 EDT 2025
Thu Apr 24 23:02:59 EDT 2025
Thu Apr 03 09:43:40 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License 2014 American Society for Nutrition.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c489t-dbbc382001e117f62721464edac0e2e24f6827da2a91a1e6ced7d90499051903
Notes http://dx.doi.org/10.3945/ajcn.113.078576
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://academic.oup.com/ajcn/article-pdf/99/6/1369/23831709/1369.pdf
PMID 24760978
PQID 1532259741
PQPubID 41076
PageCount 9
ParticipantIDs proquest_miscellaneous_1678527793
proquest_miscellaneous_1659767604
proquest_journals_1532259741
pubmed_primary_24760978
crossref_citationtrail_10_3945_ajcn_113_078576
crossref_primary_10_3945_ajcn_113_078576
fao_agris_US201500151045
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-06-01
PublicationDateYYYYMMDD 2014-06-01
PublicationDate_xml – month: 06
  year: 2014
  text: 2014-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda
PublicationTitle The American journal of clinical nutrition
PublicationTitleAlternate Am J Clin Nutr
PublicationYear 2014
Publisher American Society for Clinical Nutrition
American Society for Clinical Nutrition, Inc
Publisher_xml – name: American Society for Clinical Nutrition
– name: American Society for Clinical Nutrition, Inc
References Cavalcanti (10.3945/ajcn.113.078576_bib21) 2005; 8
Schoeller (10.3945/ajcn.113.078576_bib23) 2005; 81
Larsen (10.3945/ajcn.113.078576_bib30) 2010; 363
Pan (10.3945/ajcn.113.078576_bib25) 2004; 23
Villareal (10.3945/ajcn.113.078576_bib10) 2004; 12
Baumgartner (10.3945/ajcn.113.078576_bib18) 1998; 147
Roubenoff (10.3945/ajcn.113.078576_bib2) 2000; 54
Visser (10.3945/ajcn.113.078576_bib12) 2013; 23
Kelly (10.3945/ajcn.113.078576_bib20) 2009; 4
Heber (10.3945/ajcn.113.078576_bib13) 1996; 64
Prado (10.3945/ajcn.113.078576_bib3) 2008; 9
Roubenoff (10.3945/ajcn.113.078576_bib14) 2004; 12
Bray (10.3945/ajcn.113.078576_bib4) 2004; 89
Hsu (10.3945/ajcn.113.078576_bib22) 2005; 13
10.3945/ajcn.113.078576_bib17
10.3945/ajcn.113.078576_bib16
Roubenoff (10.3945/ajcn.113.078576_bib7) 2000; 904
Baumgartner (10.3945/ajcn.113.078576_bib8) 2000; 904
Kewalramani (10.3945/ajcn.113.078576_bib27) 2010; 13
Siervo (10.3945/ajcn.113.078576_bib5) 2012; 6
Choi (10.3945/ajcn.113.078576_bib26) 2013; 20
Ellis (10.3945/ajcn.113.078576_bib31) 1990; 26–27
Baumgartner (10.3945/ajcn.113.078576_bib9) 2004; 12
Mott (10.3945/ajcn.113.078576_bib34) 1999; 69
Flegal (10.3945/ajcn.113.078576_bib15) 2009; 89
Santarpia (10.3945/ajcn.113.078576_bib29) 2013; 32
Janssen (10.3945/ajcn.113.078576_bib1) 2004; 52
Heymsfield (10.3945/ajcn.113.078576_bib19) 1990; 52
Roubenoff (10.3945/ajcn.113.078576_bib32) 2000; 55
Lee (10.3945/ajcn.113.078576_bib11) 2012; 64
Prado (10.3945/ajcn.113.078576_bib6) 2012; 31
Waters (10.3945/ajcn.113.078576_bib33) 2011; 27
10.3945/ajcn.113.078576_bib24
Kraegen (10.3945/ajcn.113.078576_bib28) 2008; 19
27037367 - Am J Clin Nutr. 2016 Apr;103(4):1190
References_xml – volume: 54
  start-page: S40
  issue: suppl 3
  year: 2000
  ident: 10.3945/ajcn.113.078576_bib2
  article-title: Sarcopenia and its implications for the elderly
  publication-title: Eur J Clin Nutr
  doi: 10.1038/sj.ejcn.1601024
– volume: 19
  start-page: 235
  year: 2008
  ident: 10.3945/ajcn.113.078576_bib28
  article-title: Free fatty acids and skeletal muscle insulin resistance
  publication-title: Curr Opin Lipidol
  doi: 10.1097/01.mol.0000319118.44995.9a
– volume: 32
  start-page: 157
  year: 2013
  ident: 10.3945/ajcn.113.078576_bib29
  article-title: Body composition changes after weight-loss interventions for overweight and obesity
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2012.08.016
– volume: 8
  start-page: 293
  year: 2005
  ident: 10.3945/ajcn.113.078576_bib21
  article-title: Reproducibility of DXA estimations of body fat in HIV lipodystrophy: implications for clinical research
  publication-title: J Clin Densitom
  doi: 10.1385/JCD:8:3:293
– volume: 147
  start-page: 755
  year: 1998
  ident: 10.3945/ajcn.113.078576_bib18
  article-title: Epidemiology of sarcopenia among the elderly in New Mexico
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a009520
– volume: 12
  start-page: 913
  year: 2004
  ident: 10.3945/ajcn.113.078576_bib10
  article-title: Physical frailty and body composition in obese elderly men and women
  publication-title: Obes Res
  doi: 10.1038/oby.2004.111
– volume: 69
  start-page: 1007
  year: 1999
  ident: 10.3945/ajcn.113.078576_bib34
  article-title: Relation between body fat and age in 4 ethnic groups
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/69.5.1007
– volume: 4
  start-page: e7038
  year: 2009
  ident: 10.3945/ajcn.113.078576_bib20
  article-title: Dual energy X-ray absorptiometry body composition reference values from NHANES
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0007038
– volume: 52
  start-page: 80
  year: 2004
  ident: 10.3945/ajcn.113.078576_bib1
  article-title: The healthcare costs of sarcopenia in the United States
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2004.52014.x
– volume: 89
  start-page: 2583
  year: 2004
  ident: 10.3945/ajcn.113.078576_bib4
  article-title: Medical consequences of obesity
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-0535
– ident: 10.3945/ajcn.113.078576_bib17
– volume: 904
  start-page: 437
  year: 2000
  ident: 10.3945/ajcn.113.078576_bib8
  article-title: Body composition in healthy aging
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2000.tb06498.x
– volume: 20
  start-page: 85
  year: 2013
  ident: 10.3945/ajcn.113.078576_bib26
  article-title: Characteristics of metabolically obese, normal-weight women differ by menopause status: the Fourth Korea National Health and Nutrition Examination Survey
  publication-title: Menopause
  doi: 10.1097/gme.0b013e31825d26b6
– volume: 363
  start-page: 2102
  year: 2010
  ident: 10.3945/ajcn.113.078576_bib30
  article-title: Diets with high or low protein content and glycemic index for weight-loss maintenance
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1007137
– volume: 12
  start-page: 1995
  year: 2004
  ident: 10.3945/ajcn.113.078576_bib9
  article-title: Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly
  publication-title: Obes Res
  doi: 10.1038/oby.2004.250
– volume: 52
  start-page: 214
  year: 1990
  ident: 10.3945/ajcn.113.078576_bib19
  article-title: Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/52.2.214
– volume: 13
  start-page: 312
  year: 2005
  ident: 10.3945/ajcn.113.078576_bib22
  article-title: Heritability of body composition measured by DXA in the Diabetes Heart Study
  publication-title: Obes Res
  doi: 10.1038/oby.2005.42
– ident: 10.3945/ajcn.113.078576_bib24
– volume: 27
  start-page: 401
  year: 2011
  ident: 10.3945/ajcn.113.078576_bib33
  article-title: Sarcopenia and obesity
  publication-title: Clin Geriatr Med
  doi: 10.1016/j.cger.2011.03.007
– volume: 23
  start-page: 1749
  year: 2004
  ident: 10.3945/ajcn.113.078576_bib25
  article-title: A comparison of goodness of fit tests for age-related reference ranges
  publication-title: Stat Med
  doi: 10.1002/sim.1692
– volume: 81
  start-page: 1018
  year: 2005
  ident: 10.3945/ajcn.113.078576_bib23
  article-title: QDR 4500A dual-energy X-ray absorptiometer underestimates fat mass in comparison with criterion methods in adults
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/81.5.1018
– volume: 64
  start-page: 3947
  year: 2012
  ident: 10.3945/ajcn.113.078576_bib11
  article-title: Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: a cross-sectional study
  publication-title: Arthritis Rheum
  doi: 10.1002/art.37696
– volume: 13
  start-page: 382
  year: 2010
  ident: 10.3945/ajcn.113.078576_bib27
  article-title: Muscle insulin resistance: assault by lipids, cytokines and local macrophages
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0b013e32833aabd9
– volume: 904
  start-page: 553
  year: 2000
  ident: 10.3945/ajcn.113.078576_bib7
  article-title: Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2000.tb06515.x
– volume: 64
  start-page: 472S
  issue: suppl
  year: 1996
  ident: 10.3945/ajcn.113.078576_bib13
  article-title: Clinical detection of sarcopenic obesity by bioelectrical impedance analysis
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/64.3.472S
– volume: 23
  start-page: 511
  year: 2013
  ident: 10.3945/ajcn.113.078576_bib12
  article-title: Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2011.12.001
– volume: 89
  start-page: 500
  year: 2009
  ident: 10.3945/ajcn.113.078576_bib15
  article-title: Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.2008.26847
– volume: 6
  start-page: e1
  year: 2012
  ident: 10.3945/ajcn.113.078576_bib5
  article-title: Ageing, adiposity indexes and low muscle mass in a clinical sample of overweight and obese women
  publication-title: Obes Res Clin Pract
  doi: 10.1016/j.orcp.2011.05.001
– volume: 26–27
  start-page: 385
  year: 1990
  ident: 10.3945/ajcn.113.078576_bib31
  article-title: Reference man and woman more fully characterized: variations on the basis of body size, age, sex, and race
  publication-title: Biol Trace Elem Res
  doi: 10.1007/BF02992693
– ident: 10.3945/ajcn.113.078576_bib16
– volume: 31
  start-page: 583
  year: 2012
  ident: 10.3945/ajcn.113.078576_bib6
  article-title: Sarcopenic obesity: a critical appraisal of the current evidence
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2012.06.010
– volume: 12
  start-page: 887
  year: 2004
  ident: 10.3945/ajcn.113.078576_bib14
  article-title: Sarcopenic obesity: the confluence of two epidemics
  publication-title: Obes Res
  doi: 10.1038/oby.2004.107
– volume: 55
  start-page: M716
  year: 2000
  ident: 10.3945/ajcn.113.078576_bib32
  article-title: Sarcopenia: current concepts
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/55.12.M716
– volume: 9
  start-page: 629
  year: 2008
  ident: 10.3945/ajcn.113.078576_bib3
  article-title: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(08)70153-0
– reference: 27037367 - Am J Clin Nutr. 2016 Apr;103(4):1190
SSID ssj0012486
Score 2.48592
Snippet Background: Abnormal body compositions such as high adiposity (HA), low muscle mass (LM), or a combination of the 2 [high adiposity with low muscle mass...
Abnormal body compositions such as high adiposity (HA), low muscle mass (LM), or a combination of the 2 [high adiposity with low muscle mass (HA-LM)] are...
SourceID proquest
pubmed
crossref
fao
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1369
SubjectTerms Absorptiometry, Photon
adiposity
Adolescent
Adult
adults
Aged
Aged, 80 and over
Aging
Body Composition
Body Mass Index
clinical nutrition
Cross-Sectional Studies
dual-energy X-ray absorptiometry
fat mass index
Female
Genotype & phenotype
Growth Charts
Health risk assessment
Humans
Male
men
Middle Aged
muscles
Musculoskeletal system
National Health and Nutrition Examination Survey
Nutrition Surveys
Obesity
Obesity - complications
Obesity - diagnostic imaging
Obesity - epidemiology
phenotype
Prevalence
risk
Sarcopenia - complications
Sarcopenia - diagnostic imaging
Sarcopenia - epidemiology
Sex Characteristics
skeletal muscle
United States - epidemiology
Whole Body Imaging
women
Young Adult
Title population-based approach to define body-composition phenotypes
URI https://www.ncbi.nlm.nih.gov/pubmed/24760978
https://www.proquest.com/docview/1532259741
https://www.proquest.com/docview/1659767604
https://www.proquest.com/docview/1678527793
Volume 99
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdYJyFeEIyPBQYyEkJIVUriOE78WEGnia1FglT0LXIcZwKVZFozpPHXc1e7aak6NHhoVLlOHfku9-W7-xHyOoqlDopK-lUSKJ-nofJVoZUvdGhSUcYmXh4XjCfiZMo_zuLZRsU1Vpe0xUD_2llX8j9UhTGgK1bJ_gNluz-FAfgO9IUrUBiut6LxsH_R4W_5qI_Krkc42pSlqdCGLJry2sfUcZef1ce0rgZjr4tN0zRb15jUmw0lutrJetW4vxOnl6psXNbIXPXHG9jEoGx_Nq4WyGZ62cJDG_EeYVBlHYW9_rHokLItyprDgnbRiJCvs6acAJUgQCNmkWwHZseYk7oWFslx16YIDSOL3bIt2yPJsQ2G-q5rBKIZgG0TJzu6aE8-5cfTs7M8G82yPbLPwH1gPbI_PP389bQ7X2J8iQHaPZlt-oRLvNta4A97Za9Szc2uyNIkyR6Q-86XoEPLGA_JHVMfEO_DN9PSN9Q1fJ3TyYpsB-Tu2GVSPCLDId3mHbriHdo21PIO3eYduuadxyQ7HmXvT3wHp-FrnsrWL4tCRynm0JkwTCrBEgR156ZUOjDMMF6JlCWlYkqGKjRCmzIpJbrEaOYH0RPSq5vaHBIqMB1VcmMKznhhZCG05DCkmA7iKtYeGaz2LNeu1TwinsxzcDlxk3PcZHA-o9xuskfedjdc2C4rN089BCLk6hx0YD79wjBiB58QXBOPHK0ok7vXZJGDRgeVBV5z6JFX3c8gQ_FgTNWmuYI5AiaIRAT8b3NgeWAmGXnkqaV696iMw70ySZ_dYoXn5N76vTkivfbyyrwAu7YtXjom_Q2kMqHc
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+population-based+approach+to+define+body-composition+phenotypes&rft.jtitle=The+American+journal+of+clinical+nutrition&rft.au=Prado%2C+Carla+M+M&rft.au=Siervo%2C+Mario&rft.au=Mire%2C+Emily&rft.au=Heymsfield%2C+Steven+B&rft.date=2014-06-01&rft.issn=1938-3207&rft.eissn=1938-3207&rft.volume=99&rft.issue=6&rft.spage=1369&rft_id=info:doi/10.3945%2Fajcn.113.078576&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9165&client=summon